Abstract
Objective
While research found heterogeneous changes in mental health during the COVID-19 pandemic, less is known about the long-term changes in mental health in psychiatric groups. Therefore, we applied a data-driven method to detect sub-groups with distinct trajectories across two years into the pandemic in psychiatric groups, and described their differences in socio-demographic and clinical characteristics.
Method
We conducted sixteen rounds of questionnaires between April 2020 and February 2022 among participants (n = 1722) of three psychiatric case–control cohorts that started in the 2000's. We used Growth Mixture Modelling and (multinomial) logistic regression to identify characteristics associated with trajectory membership.
Results
We found low decreasing (1228 [72%] participants), intermediate (n = 348 [22%] participants) and high stable (106 [6%] participants) trajectories of depressive symptoms; decreasing low/intermediate (1507 [90%] participants) and high stable (161 [10%] participants) trajectories of anxiety symptoms; and stable low (1109 [61%] participants), stable high (315 [17%] participants), temporary lowered (123 [9%]) and temporary heightened (175 [13%] participants) trajectories of loneliness. Chronicity and severity of pre-pandemic mental disorders predicted unfavourable sub-group membership for all outcomes. Being female, having a low education and income level were associated with unfavourable trajectories of depression, being younger with unfavourable trajectories of anxiety and being female and living alone with unfavourable trajectories of loneliness.
Conclusion
We found relatively stable trajectories of depression and anxiety symptoms over two years, suggesting low heterogeneity in outcomes during the pandemic. For loneliness, we found two specific sub-groups with temporary increase and decrease in loneliness during the pandemic.
Keywords: Depressive symptoms, Anxiety symptoms, Loneliness, COVID-19 pandemic, Growth mixture modelling
1. Introduction
Lockdowns implemented to reduce the spread of coronavirus disease 2019 (COVID-19) expected to large impact on people's mental health, particularly in people with pre-existing psychiatric disorders. However, studies hitherto yielded different findings concerning changes in mental health symptoms over the course of the pandemic. Some found a substantial increase in depressive and anxiety symptoms [[1], [2], [3]], while others found surprisingly small increases among young and older adults [[4], [5], [6], [7], [8]] during the first months of the pandemic. Longitudinal studies did observe an initial upsurge of mental health symptoms during the first lockdown, yet this was followed by a gradual decline afterwards [[9], [10], [11], [12], [13], [14]]. Findings for loneliness showed larger, though still modest, average increases [15]. Similarly, in a previous study by our group, we found that depressive and anxiety symptoms were surprisingly stable across the COVID-19 pandemic's first year, yet loneliness levels substantially increased compared to pre-pandemic levels in groups with and without depressive, anxiety and obsessive-compulsive disorders (OCD) [16].
However, such conclusions are often based on average changes in mental health, sometimes stratified for a priori defined demographic or clinical characteristics. For instance, some studies found that lower socioeconomic position, female sex, younger age were associated with worse mental health trajectories [9,10,17,18]. Despite the merits of these studies, it has been suggested that the predominant focus on existing socio-demographic predictors is too deterministic and hides subpopulations with distinctive worsening, improving or stabilizing trajectories [17]. Therefore, applying a data-driven approach to detect sub-groups with distinct trajectories of mental health, and broadly explore characteristics of these sub-groups may be a valuable complementary approach to previous research.
Various studies have used such a data-driven, mixture modelling approach to capture mental health trajectories during the pandemic [11,17,[19], [20], [21], [22], [23]]. For example, two UK-based studies found five and four sub-groups with distinct trajectories of mental distress, with 53–76% of the population experiencing persistently low and very low distress levels, 11–15% experiencing continuously elevated distress levels and 8–12% experiencing recovery or only temporary elevated distress levels [11,17]. Another UK-based study [22] observed patterns that were more or less similar for anxiety and depression with about 73% experiencing stable low trajectories, about 6% stable high trajectories and about 4% experiencing recovering and about 15% experiencing stable medium trajectories of depressive and anxiety symptoms. Finally, for loneliness, another UK-based study found four sub-groups. Loneliness levels increased slightly in the highest loneliness group (14%), decreased slightly in the lowest loneliness group (48%), and stayed relatively constant in the middle two groups (23% and 14%) [19]. Overall, findings suggest that there was significant heterogeneity in mental health trajectories during the pandemic, but that the majority of the population experienced relatively favourable mental health trajectories.
Nevertheless, knowledge on the impact of the pandemic on mental health can be expanded in three important ways. First, so far, the majority of data-driven studies covered only the year 2020 [11,[19], [20], [21], [22], [23], [24]] with a few exceptions lasting until mid-May 2021 [17] and December 2021 [25]. Therefore, knowledge on long-term mental health trajectories is limited. Specifically unknown are the changes since the upsurge of the Omicron variant of COVID-19, which was detected in Europe in December 2021 and evoked re-instalment of lockdown measures in many countries. Second, the majority of data-driven studies have been conducted in the UK [11,17,19,21,22], with some exceptions in Canada [24] Australia [20] and Israel [26]. As country-level contextual factors may affect mental health consequences [27], studies in other countries are warranted. Third, most data-driven studies were conducted in the general population [11,17,[19], [20], [21], [22],24,25] and found that pre-pandemic mental health status is strongly associated with unfavourable (i.e. consistently high level of symptoms) mental health trajectories [5,10,12,13]. Nevertheless, specific studies in psychiatric cohorts that have more detailed pre-pandemic information on this high-risk population are lacking. In sum, there is a need for in-depth research on long-term mental health trajectories among psychiatric groups during the COVID-19 pandemic that can reveal the role of pre-pandemic mental health history (e.g. chronicity of disorders) and examine heterogeneity in trajectories within this specific population.
In the Netherlands, the setting of the current study, the first national lockdown began in February 2020 and lasted until June 2020, after which the COVID-19 infections eased over the summer. In the fall of 2020 there was a new surge in COVID-19 infections, resulting first in a partial lockdown starting in October 2020 followed by a hard lockdown in December 2020, including a night-time curfew and complete closure of non-essential stores. COVID-19 infections eased over the summer of 2021 but cases started to rise again in October 2021, after which a last partial lockdown was implemented from November 2021 until January 2022, when due to the Omicron-variant the daily number of known infections peaked at >80,000 on a total of 17 m inhabitants.
Based on data spanning this entire period, in the present study we take a data-driven mixture modelling approach, similar to previous studies, but focusing specifically on persons with psychiatric disorders in the Netherlands. We investigate whether mental health trajectories are associated with chronicity of pre-pandemic mental health disorders and demographic characteristics.
2. Materials and methods
2.1. Study sample and design
We used data from three Dutch prospective cohort studies with largely identical methods for collecting pre-pandemic data: the Netherlands Study of Depression and Anxiety (NESDA) [28], the Netherlands Study of Depression in Older Persons (NESDO) [29], and Netherlands OCD Association Study (NOCDA, baseline: 2004) [30].
For NESDA, participants with a depressive or anxiety disorder (n = 2329), their biological siblings (n = 367), and controls without mental disorder (n = 652) were recruited from specialized mental health care, primary care and the community. When the baseline measurement took place in 2004–2007, participants were aged between 18 and 35 years. Follow-up measurements were conducted in 2008–11, 2010–13, and 2014–16.
For NESDO, participants with a primary diagnosis of depressive disorder (n = 378) and controls without lifetime diagnoses of mental health disorders (n = 132) were recruited from specialized mental health care and primary care. Participants were aged between 60 and 93 years at baseline in 2007–2010 and follow-up measurements took place in 2008–12, and 2012–16.
For NOCDA, participants with a lifetime diagnosis of obsessive-compulsive disorder (n = 419) were recruited from mental health-care institutions. Participants were aged 18–65 years at baseline in 2004–2009 and follow-up measurements took place in 2006–11, 2008–13, and 2012–16.
Participants who gave permission to be re-contacted, were invited to partake in the “COVID-19 questionnaire” via e-mail (n = 2748). Between April 1, 2020 until February 2022, participants partook in sixteen online measurements, which were held two to eight weeks apart. An exception was the last measurement in February 2022, which was held 7 months after the prior measurement in July 2021.
In the present analyses we included participants, both cases and controls, who had data on each mental health outcome during at least one COVID-19 measurement wave (depressive symptoms: n = 1681, anxiety symptoms: n = 1722 and loneliness: n = 1667). For all pre-COVID-19 measurements written consent was obtained and for during-COVID-19 measurements consent was obtained in electronic form. All study procedures were approved by the Institutional Review Board of the Vrije Universiteit Medical Center, Amsterdam (reference number 2020.166).
2.2. Mental health outcomes
Depressive symptoms were assessed using the 16-item Quick Inventory of Depressive Symptoms (QIDS) [31]. Items assessed symptoms of depressive disorder according to DSM-IV criteria, for instance depressed mood. Each item was scored on a scale of 0–3, with higher scores denoting greater symptom severity. The total score ranged from 0 to 27.
Anxiety symptoms were assessed using the Beck Anxiety Inventory (BAI) [32]. Participants were asked to what extent 21 anxiety symptoms (e.g. scared and fear of losing control) bothered them in the past week, with answer categories ranging from 0 (not at all) to 3 (severely) and with a total score ranging from 0 to 63.
Loneliness, both social and emotional, was obtained using the 6-item De Jong Gierveld Loneliness Scale [33]. An example item includes “I miss having people around”. Answer categories ranged from 0 (no) to 2 (yes) and categories 1 (more or less) and 2 (yes) were collapsed, resulting in a total score ranging from 0 to 6.
2.3. Socio-demographic and mental health characteristics
In line with previous work [34], chronicity of mental disorders reflected the percentage of waves since 2006 in which the participants had any 1-year diagnosis of depressive disorder, anxiety disorder or OCD. This was categorized into No lifetime disorder (i.e. ‘healthy controls’); Remitted Disorder (NOCDA and NESDA participants who only had lifetime disorders but no waves with 1-year disorders); Low-medium Chronicity (1–50% of previous measurements with disorders); and High Chronicity (51–100% of previous measurements with disorders). Included disorders were major depressive disorder, dysthymia, general anxiety disorder, panic disorder, social phobia, and agoraphobia for all three cohorts, and additionally obsessive-compulsive disorder in NOCDA. In NESDA and NESDO, diagnoses were based on the Composite Interview Diagnostic Interview (CIDI [35]), using DSM-IV criteria. In NOCDA, diagnoses were based on the Structured Clinical Interview for DSM-IV axis-I disorders (SCID [36]).
Pre-pandemic socio-demographic and health characteristics included sex (female and male), education level (low [elementary school to general secondary education] and high [college or university]), income (monthly household income in euros), living alone (no and yes), number of chronic diseases (self-reported). In line with previous work [34], pre-pandemic depressive and anxiety symptoms and loneliness levels were based on the mean number of symptoms from all available waves between 2006 and 2016, except for the baseline.
COVID-19-related characteristics included perceived mental health impact (based on nine items; observed range: 1.0–4.7), fear of COVID-19 (six items; observed range: 1.4–5.0) and positive coping (five items; observed range: 1.7–5.0) see also: [34] and Table S1). Furthermore, we included COVID-19 infection (no and yes), received treatment during (no and yes), and psychotropic medication use (no and yes) both during the COVID-19 pandemic.
2.4. Procedure
We generated descriptive statistics of socio-demographic, clinical (chronicity and severity of pre-pandemic mental health disorders) and COVID-19 related characteristics and investigated differences across chronicity groups using F-tests (ANOVA) and χ2 tests, as appropriate (Table S2).
To identify sub-groups with distinct trajectories of depressive and anxiety symptoms and loneliness during COVID-19, we conducted Growth Mixture Modelling (GMM) [37] for each mental health outcome separately. The goal of this analysis was to identify sub-groups with distinct type of trajectories of depressive and anxiety symptoms and loneliness during the COVID-pandemic, based on a data-driven method.
GMM followed two subsequent steps [37,38]. First, we established baseline latent growth model comparing linear, quadratic, and cubic single-class models in order to find the best single-class representation of change. Second, we estimated a series of models with an increasing number of classes (a ‘class’ is a sub-group with a distinct type of trajectory). We used a combination of model fit criteria to determine the best fitting models: lower Bayesian and adjusted Bayesian information criteria (BIC and aBIC [39]), higher entropy and posterior class membership probabilities [40], adjusted Lo-Mendell-Rubin likelihood ratio test comparing the fit of the k-class model with the fit of the k-1 class [41,42], class size reflecting at least 5% of the total sample, and interpretability of emerging classes based on theory and distinctiveness [38]. This process was repeated until we found a class solution that exhibited both reasonable fit statistics and made theoretical sense.
To estimate associations between pre-pandemic chronicity of psychiatric disorders and other characteristics and most likely class membership, we used multinomial logistic regression. Because of missingness in the covariates (e.g. income (21%), number of chronic diseases (19%), and living alone (9%)) we could not account for classification uncertainty in these analyses by for example using the R3STEP-method, as this altered the sample size and assignment to latent classes. However, because entropy values, which denote the quality of class separation, were high, bias due to misspecification is likely limited [40,43]. The multinomial logistic regression Model 1 included chronicity of pre-pandemic mental health disorders, Model 2 additionally included socio-demographic characteristics, and Model 3 additionally included pre-pandemic depressive and anxiety symptoms and loneliness. All analysis we performed in Mplus Version 8.5 and SPSS version 26. In Mplus, we used maximum likelihood estimation under the missing at random (MAR) to handle missing data. In SPSS, we used multiple imputation for the predictors, with 21 imputed datasets, in line with the % of participants with at least one missing value.
3. Results
3.1. Depressive symptoms
The 3-class model had optimal fit. Comparison of BIC and aBIC indices of the linear and quadratic models indicated a model with a quadratic slope had the best fit (Table 1 ). A series of GMMs was performed with up to 5 classes. The BIC indicated improvement for each model and aBIC indicated improvement up to the 5 class model. However, class solutions above 3-classes yielded sub-group sizes of below 5% of the sample. In addition, The aLMR-LRT was nonsignificant in the 4-class solution, suggesting no significant improvement beyond the 3-class model.
Table 1.
fit indices for GMM outcomes depressive symptoms. Anxiety symptoms and loneliness.
Depressive symptoms | Class size | BIC | aBIC | aLMR-LRT | p | Entropy | PMP |
---|---|---|---|---|---|---|---|
Baseline model with a single class | |||||||
Linear | 1682 | 59,508 | 59,441 | ||||
Quadratic | 1682 | 59,363 | 59,283 | ||||
Cubic* | 1682 | – | – | ||||
GMM 2–5 classes (Quadratic) | |||||||
2-class | 1389; 293 | 58,988 | 58,896 | 391 | 0.003 | 0.833 | 0.85–0.97 |
3-class | 106; 348; 1228 | 58,858 | 58,753 | 155 | 0.007 | 0.827 | 0.80–0.85 |
4-class | 302; 1220; 109; 51 | 58,760 | 58,642 | 124 | 0.21 | 0.806 | 0.42–0.97 |
5-class | 98; 35; 37; 294; 1218 | 58,714 | 58,584 | 72 | 0.18 | 0.806 | 0.35–0.98 |
Anxiety | |||||||
Baseline model with a single class | |||||||
Linear | 1668 | 72,005 | 71,938 | ||||
Quadratic | 1668 | 71,917 | 71,837 | ||||
Cubic | 1668 | 71,917 | 71,837 | ||||
GMM 2–5 classes (quadratic) | |||||||
2-class | 1507; 161 | 71,412 | 71,320 | 518 | <0.001 | 0.919 | 0.86–0.99 |
3-class | 48; 286; 1334 | 71,178 | 71,073 | 255 | 0.10 | 0.909 | 0.87–0.98 |
4-class | 1332; 197; 94; 45 | 70,987 | 70,869 | 212 | 0.52 | 0.888 | 0.62–0.98 |
5-class | 1306; 210; 86; 51; 15 | 70,905 | 70,774 | 108 | 0.75 | 0.897 | 0.63–0.98 |
Loneliness | BIC | aBIC | aLMR-LRT | p | Entropy | PMP | |
---|---|---|---|---|---|---|---|
Baseline model with a single class | |||||||
Linear | 1723 | 41,466 | 41,399 | ||||
Quadratic | 1723 | 41,393 | 41,314 | ||||
Cubic* | 1723 | – | – | ||||
GMM 2–5 classes (Quadratic) Note: model where variation around the quadratic slope is set to 0 | |||||||
2-class | 1258; 465 | 41,015 | 40,933 | 453 | <0.001 | 0.835 | 0.93–0.97 |
3-class | 390; 1238; 95 | 40,885 | 40,790 | 155 | <0.001 | 0.796 | 0.47–0.98 |
4-class | 124; 175; 1109; 315 | 40,789 | 40,681 | 121 | 0.31 | 0.767 | 0.56–0.97 |
5-class | 151; 1089; 29; 325; 129 | 40,732 | 40,611 | 84 | 0.14 | 0.770 | 0.51–0.97 |
Note: model where variation around the quadratic slope is set to 0, BIC = Bayesian information criteria. aBIC = adjusted Bayesian information criteria, aLMR-LRT = adjusted Lo-Mendell-Rubin likelihood ratio test. and PMP = posterior class membership probabilities *the cubic model was not specified due to the fact that the cubic slope was nearly zero in these models.
In the 3-class model, a majority (C#1: n = 1228; 72%) experienced a low decreasing level of depressive symptoms. 22% (C#2: N = 348) had an intermediate trajectory and 6% (C#3: n = 106) experienced a stable high level of depressive symptoms (Fig. 1 ). The negative linear slope of class #1 was statistically significant (S = −1.07, p = 0.048; Table S3). Descriptive statistics of chronicity of pre-pandemic mental health disorders, socio-demographic and pre-pandemic mental health characteristics across classes are depicted in Table S4.
Fig. 1.
Change trajectory profiles of depressive and anxiety symptoms and loneliness compared to pre-Covid-19 levels.
Upper left panel: Average and standard error of the number of depressive symptoms per class across 16 COVID-19 measurements (n = 1682). Upper right panel: Average and standard error of anxiety symptoms per class across 16 COVID-19 measurements (n = 1668). Lower right panel: Average and standard error of loneliness per class across 16 COVID-19 measurements (n = 1723). Lower right panel: daily number of COVID-19 deaths during the pandemic in the Netherlands, with a sliding mean in dark blue. Key dates with regard to COVID-19 and its Dutch (lockdown) measures are given. Source: https://data.rivm.nl/meta/srv/dut/catalog.search#/metadata/2c4357c8-76e4-4662-9574-1deb8a73f724
Multinominal logistic regression was performed to determine which socio-demographic and mental health characteristics were associated with trajectory membership (Table 2 ). Model 1 included chronicity of pre-pandemic psychiatric disorders and revealed that individuals with higher chronicity (i.e. medium and high) were more likely to experience stable high and intermediate compared to low and decreasing trajectories. The association remained statistically significant in model 2 where socio-demographic characteristics (i.e. age, sex, education level, living alone, number of chronic diseases) were added and in model 3 where pre-pandemic mental health symptoms were added. Model 2 also showed that individuals with a high education level were less likely to experience an intermediate and stable high trajectories, and individuals with higher income and living alone were more likely to experience an intermediate trajectory all compared the likelihood of experiencing a low and decreasing trajectory. When additionally adjusting for pre-pandemic mental health (model 3),the association with pre-pandemic mental health symptoms was no longer significant, while females were more likely to experience an intermediate trajectory.
Table 2.
association between pre-pandemic demographic and health characteristics and class membership for depressive symptoms.
Intermediate (vs. low decreasing) | Model 1 |
Model 2 |
Model 3 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OR | SE | 95% CI |
P | OR | SE | 95% CI |
P | OR | SE | 95% CI |
P | ||||
lower | upper | lower | upper | lower | upper | ||||||||||
Remitted disorder (vs. healthy controls) | 2.73 | 1.32 | 1.58 | 4.73 | <0.001 | 2.80 | 1.33 | 1.61 | 4.86 | <0.001 | 1.76 | 1.34 | 0.99 | 3.14 | 0.06 |
Low medium chronicity (vs. healthy controls) | 6.24 | 1.30 | 3.73 | 10.43 | <0.001 | 6.35 | 1.31 | 3.77 | 10.71 | <0.001 | 1.98 | 1.34 | 1.12 | 3.49 | 0.02 |
High chronicity (vs. healthy controls) | 16.09 | 1.29 | 9.71 | 26.68 | <0.001 | 16.33 | 1.30 | 9.73 | 27.43 | <0.001 | 2.38 | 1.36 | 1.29 | 4.37 | 0.005 |
Age | 1.00 | 1.01 | 0.99 | 1.01 | 0.55 | 0.99 | 1.01 | 0.98 | 1.00 | 0.19 | |||||
Sex: women (vs. men) | 1.21 | 1.15 | 0.92 | 1.61 | 0.18 | 1.61 | 1.18 | 1.17 | 2.23 | 0.003 | |||||
education: high (vs. Low) | 0.79 | 1.15 | 0.60 | 1.04 | 0.09 | 0.91 | 1.17 | 0.67 | 1.24 | 0.55 | |||||
Income | 1.01 | 1.01 | 1.00 | 1.03 | 0.05 | 1.03 | 1.01 | 1.02 | 1.05 | <0.001 | |||||
Living alone: yes (vs no) | 1.92 | 1.19 | 1.36 | 2.72 | <0.001 | 2.16 | 1.21 | 1.48 | 3.17 | <0.001 | |||||
Number of chronic diseases | 1.08 | 1.08 | 0.93 | 1.26 | 0.31 | 0.91 | 1.09 | 0.77 | 1.09 | 0.31 | |||||
Average pre-COVID depressive symptom | 1.30 | 1.03 | 1.22 | 1.38 | <0.001 | ||||||||||
Average pre-COVID anxiety symptoms | 1.04 | 1.01 | 1.01 | 1.07 | 0.004 | ||||||||||
Average pre-COVID loneliness | 1.11 | 1.04 | 1.02 | 1.20 | 0.02 | ||||||||||
High stable (vs. low decreasing) | |||||||||||||||
Remitted disorder (vs. healthy controls) | 2.02 | 1.85 | 0.60 | 6.77 | 0.25 | 1.76 | 1.86 | 0.52 | 5.98 | 0.36 | 0.77 | 1.86 | 0.20 | 3.01 | 0.71 |
Low medium chronicity (vs. healthy controls) | 4.56 | 1.76 | 1.51 | 13.78 | 0.007 | 3.75 | 1.77 | 1.22 | 11.51 | 0.02 | 0.56 | 1.77 | 0.16 | 1.96 | 0.36 |
High chronicity (vs. healthy controls) | 34.69 | 1.68 | 12.53 | 96.07 | <0.001 | 25.76 | 1.71 | 9.04 | 73.38 | <0.001 | 0.85 | 1.71 | 0.24 | 3.02 | 0.80 |
Age | 0.99 | 1.01 | 0.97 | 1.01 | 0.21 | 0.98 | 1.01 | 0.96 | 1.00 | 0.08 | |||||
Sex: women (vs. men) | 1.02 | 1.27 | 0.64 | 1.62 | 0.94 | 1.87 | 1.27 | 1.06 | 3.27 | 0.03 | |||||
education: high (vs. Low) | 0.56 | 1.29 | 0.34 | 0.94 | 0.03 | 0.66 | 1.29 | 0.37 | 1.18 | 0.03 | |||||
Income | 0.98 | 1.02 | 0.95 | 1.02 | 0.33 | 1.02 | 1.02 | 0.99 | 1.06 | 0.17 | |||||
Living alone: yes (vs no) | 1.82 | 1.40 | 0.93 | 3.56 | 0.08 | 2.54 | 1.40 | 1.21 | 5.33 | 0.19 | |||||
Number of chronic diseases | 1.17 | 1.14 | 0.91 | 1.51 | 0.21 | 0.86 | 1.14 | 0.62 | 1.18 | 0.34 | |||||
Average pre-COVID Depressive symptom | 1.67 | 1.00 | 1.50 | 1.85 | <0.001 | ||||||||||
Average pre-COVID anxiety symptoms | 1.04 | 1.00 | 1.00 | 1.08 | 0.08 | ||||||||||
Average pre-COVID loneliness | 1.11 | 1.00 | 0.96 | 1.29 | 0.15 |
3.2. Anxiety symptoms
For anxiety symptoms we selected the 2-class model. Differences in BIC and aBIC indices suggested optimal fit of a model with a quadratic slope (Table 1). Although the BIC, aBIC kept indicating model improvement, the aLMR-LRT indicated no significant improvement of the 3-class compared to the 2-class model. In addition, in the 3-class model, the smallest sub-group included <5% of the sample, which further disqualified this solution.
The majority of the sample experienced decreasing low/intermediate trajectory of anxiety symptoms (C#1: n = 1507; 90%) and a small portion experienced a high stable trajectory of anxiety symptoms (C#2: n = 161; 10%). Only the negative linear (S = −1.373, p = 0.001) and the positive quadratic (S = 0.118, p = 0.09) slope of decreasing low/intermediate trajectory was statistically significant. Descriptive statistics of characteristics across classes are depicted in Table S5.
Results of the association between socio-demographic and health characteristics and latent class trajectory obtained with a logistic regression are depicted in Table 3 . Compared to healthy controls, all chronicity levels (i.e. remittent, medium and high) were positively associated with experiencing a high stable as opposed a decreasing low/intermediate trajectory. After adjusting for socio-demographic characteristics in model 2, only the positive association between medium and high chronicity and high stable trajectory remained. Older and individuals with a high education level were less, and individuals with a higher income more likely to experience a high stable trajectory compared a decreasing low/intermediate trajectory. In model 3, which included pre-pandemic mental health symptoms, all positive associations between chronicity and trajectory membership disappeared but the negative association with age remained statistically significant.
Table 3.
association between pre-pandemic demographic and health characteristics and class membership for anxiety symptoms.
High stable (vs. decreasing low/intermediate) | Model 1 |
Model 2 |
Model 3 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OR |
SE |
95% CI |
P |
OR |
SE |
95% CI |
P |
OR |
SE |
95% CI |
P |
||||
lower | upper | lower | upper | upper | lower | ||||||||||
Remitted disorder (vs. healthy controls) | 3.52 | 1.76 | 1.16 | 10.71 | 0.03 | 2.89 | 1.77 | 0.94 | 8.85 | 0.06 | 1.76 | 1.81 | 0.55 | 5.63 | 0.34 |
Low medium chronicity (vs. healthy controls) | 8.95 | 1.70 | 3.16 | 25.34 | <0.001 | 7.01 | 1.71 | 2.46 | 20.02 | <0.001 | 2.37 | 1.76 | 0.78 | 7.15 | 0.13 |
High chronicity (vs. healthy controls) | 29.32 | 1.67 | 10.68 | 80.45 | <0.001 | 20.68 | 1.68 | 7.44 | 57.49 | <0.001 | 1.96 | 1.80 | 0.62 | 6.21 | 0.25 |
Age | 0.98 | 1.01 | 0.97 | 1.00 | 0.03 | 0.98 | 1.01 | 0.96 | 1.00 | 0.03 | |||||
Sex: women (vs. men) | 1.19 | 1.22 | 0.81 | 1.75 | 0.38 | 1.42 | 1.26 | 0.90 | 2.23 | 0.13 | |||||
Education: high (vs. Low) | 0.67 | 1.23 | 0.45 | 1.00 | 0.048 | 0.85 | 1.26 | 0.54 | 1.33 | 0.48 | |||||
Income | 0.97 | 1.01 | 0.95 | 1.00 | 0.03 | 0.99 | 1.01 | 0.96 | 1.01 | 0.28 | |||||
Living alone: yes (vs no) | 1.15 | 1.28 | 0.70 | 1.87 | 0.58 | 1.19 | 1.33 | 0.68 | 2.07 | 0.54 | |||||
Number of chronic diseases | 1.14 | 1.10 | 0.94 | 1.39 | 0.18 | 0.92 | 1.13 | 0.73 | 1.17 | 0.50 | |||||
Average pre-COVID depressive symptom | 1.03 | 1.04 | 0.96 | 1.12 | 0.39 | ||||||||||
average pre-COVID anxiety symptoms | 1.17 | 1.02 | 1.13 | 1.22 | <0.001 | ||||||||||
Average pre-COVID loneliness | 1.03 | 1.06 | 0.91 | 1.16 | 0.65 |
3.3. Loneliness
3.3.1. In contrast in depression and anxiety
For loneliness we selected a 4-class model. The model with a quadratic slope fitted the data best (Table 1). While the aLMR-LRT indicated no significant improvement in models with more than three classes, the BIC and aBIC still suggested a substantially improved model fit, and all class sizes remained >5%. Moreover, the smallest class-size remained above the cut-off of 5% and the intercepts, slopes and quadratic slopes were statistically significant in most classes of the 4-class model (Table S2).
The two largest sub-groups experienced stable low (C#1: n = 1109; 61%) and stable high (C#2: n = 315; 17%) trajectories of loneliness, respectively. A third sub-group experienced a temporary lowered level followed by a gradual return to their initial (high) level (C#3: n = 123; 9%). A fourth sub-group experienced a temporary heightened level followed by a recovery in 2022 (C#4: n = 175; 13%). Descriptive statistics of chronicity, socio-demographic and pre-pandemic mental health characteristics are depicted in Table S6.
Multinomial regression (Table 4 ) showed that compared to individuals experiencing a stable low trajectory, higher pre-pandemic chronicity of mental health disorders was associated with higher odds of experiencing stable high, temporary lowered and temporary heightened trajectories. After adjusting for demographic characteristics, in model 2, associations between pre-pandemic chronicity of mental health disorders remained. Individuals with a low education level and living alone were more likely to be categorized in stable high trajectories. Older men and individuals with a lower income were more likely to be categorized in temporary heightened trajectories. After adjusting for pre-pandemic mental health symptoms, the association between chronicity of mental health disorders and trajectory membership became non-significant. In addition, only in the final model, women and individuals living alone were more likely to be classified in stable high compared to stable low.
Table 4.
association between pre-pandemic demographic and health characteristics and class membership for loneliness.
Stable high (vs. stable low) | Model 1 |
Model 2 |
Model 3 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OR |
SE |
95% CI |
P |
OR |
SE |
95% CI |
P |
OR |
SE |
95% CI |
P |
||||
lower | upper | lower | upper | lower | upper | ||||||||||
Remitted disorder (vs. healthy controls) | 2.24 | 1.30 | 1.35 | 3.73 | <0.001 | 2.07 | 1.30 | 1.23 | 3.48 | 0.006 | 1.32 | 1.33 | 0.76 | 2.30 | 0.33 |
Low medium chronicity (vs. healthy controls) | 4.30 | 1.28 | 2.66 | 6.97 | 0.002 | 3.71 | 1.29 | 2.26 | 6.10 | <0.001 | 1.29 | 1.33 | 0.74 | 2.25 | 0.37 |
High chronicity (vs. healthy controls) | 9.72 | 1.27 | 6.11 | 15.45 | <0.001 | 7.64 | 1.28 | 4.71 | 12.40 | <0.001 | 1.23 | 1.37 | 0.67 | 2.26 | 0.51 |
Age | 1.00 | 1.01 | 0.99 | 1.01 | 0.99 | 0.99 | 1.01 | 0.98 | 1.01 | 0.35 | |||||
Sex: women (vs. men) | 1.00 | 1.16 | 0.75 | 1.34 | 0.99 | 1.43 | 1.18 | 1.03 | 1.99 | 0.03 | |||||
Education: high (vs. Low) | 0.73 | 1.16 | 0.54 | 0.99 | 0.04 | 0.93 | 1.18 | 0.67 | 1.29 | 0.67 | |||||
Income | 0.98 | 1.01 | 0.97 | 1.00 | 0.06 | 1.00 | 1.01 | 0.98 | 1.02 | 0.99 | |||||
Living alone: yes (vs no) | 1.98 | 1.21 | 1.36 | 2.88 | <0.001 | 2.05 | 1.22 | 1.38 | 3.03 | <0.001 | |||||
Number of chronic diseases | 1.19 | 1.09 | 1.00 | 1.42 | 0.05 | 1.04 | 1.10 | 0.86 | 1.25 | 0.71 | |||||
Average pre-COVID depressive symptom | 1.13 | 1.03 | 1.07 | 1.21 | <0.001 | ||||||||||
Average pre-COVID anxiety symptoms | 1.01 | 1.01 | 0.98 | 1.04 | 0.49 | ||||||||||
Average pre-COVID loneliness | 1.69 | 1.05 | 1.54 | 1.85 | <0.001 | ||||||||||
Temporary lowered (vs. stable low) | |||||||||||||||
Remitted disorder (vs. healthy controls) | 1.94 | 1.38 | 1.04 | 3.63 | 0.04 | 2.03 | 1.38 | 1.08 | 3.84 | 0.03 | 1.46 | 1.40 | 0.76 | 2.82 | 0.26 |
Low medium chronicity (vs. healthy controls) | 3.00 | 1.36 | 1.64 | 5.48 | <0.001 | 3.07 | 1.37 | 1.66 | 5.70 | <0.001 | 1.45 | 1.41 | 0.74 | 2.84 | 0.28 |
high chronicity (vs. healthy controls) | 3.67 | 1.36 | 2.00 | 6.73 | <0.001 | 3.66 | 1.38 | 1.95 | 6.86 | <0.001 | 1.01 | 1.49 | 0.46 | 2.22 | 0.97 |
Age | 1.01 | 1.01 | 0.99 | 1.02 | 0.40 | 1.00 | 1.01 | 0.99 | 1.02 | 0.79 | |||||
Sex: women (vs. men) | 0.85 | 1.22 | 0.57 | 1.26 | 0.41 | 1.08 | 1.24 | 0.72 | 1.64 | 0.71 | |||||
Education: high (vs. Low) | 1.04 | 1.23 | 0.69 | 1.55 | 0.86 | 1.25 | 1.24 | 0.83 | 1.90 | 0.29 | |||||
Income | 1.00 | 1.01 | 0.98 | 1.02 | 0.996 | 1.01 | 1.01 | 0.99 | 1.03 | 0.33 | |||||
Living alone: yes (vs no) | 1.39 | 1.28 | 0.86 | 2.25 | 0.18 | 1.41 | 1.29 | 0.85 | 2.32 | 0.18 | |||||
number of chronic Diseases | 1.15 | 1.12 | 0.93 | 1.42 | 0.20 | 1.04 | 1.12 | 0.83 | 1.30 | 0.76 | |||||
Average pre-COVID depressive symptom | 1.07 | 1.04 | 0.98 | 1.16 | 0.14 | ||||||||||
Average pre-COVID anxiety symptoms | 1.01 | 1.02 | 0.98 | 1.06 | 0.46 | ||||||||||
Average pre-COVID loneliness | 1.56 | 1.06 | 1.38 | 1.76 | <0.001 | ||||||||||
Temporary heightened (vs. stable low) | |||||||||||||||
Remitted disorder (vs. healthy controls) | 1.39 | 1.31 | 0.82 | 2.37 | 0.22 | 1.40 | 1.32 | 0.81 | 2.40 | 0.23 | 1.06 | 1.33 | 0.61 | 2.30 | 0.83 |
Low medium chronicity (vs. healthy controls) | 2.79 | 1.28 | 1.71 | 4.55 | <0.001 | 2.75 | 1.29 | 1.66 | 4.56 | <0.001 | 1.48 | 1.33 | 0.85 | 2.25 | 0.17 |
High chronicity (vs. healthy controls) | 3.18 | 1.29 | 1.94 | 5.23 | <0.001 | 3.06 | 1.30 | 1.82 | 5.16 | <0.001 | 1.05 | 1.40 | 0.54 | 2.26 | 0.88 |
Age | 1.02 | 1.01 | 1.00 | 1.03 | 0.01 | 1.01 | 1.01 | 1.00 | 1.01 | 0.05 | |||||
Sex: women (vs. men) | 0.60 | 1.19 | 0.43 | 0.84 | 0.003 | 0.73 | 1.19 | 0.51 | 1.99 | 0.07 | |||||
Education: high (vs. Low) | 0.94 | 1.20 | 0.66 | 1.34 | 0.73 | 1.06 | 1.21 | 0.73 | 1.29 | 0.76 | |||||
Income | 0.98 | 1.01 | 0.96 | 1.00 | 0.04 | 0.99 | 1.01 | 0.97 | 1.02 | 0.21 | |||||
Living alone: yes (vs no) | 1.01 | 1.25 | 0.65 | 1.58 | 0.95 | 1.02 | 1.26 | 0.65 | 3.03 | 0.93 | |||||
Number of chronic diseases | 0.98 | 1.11 | 0.80 | 1.19 | 0.82 | 0.90 | 1.11 | 0.74 | 1.25 | 0.34 | |||||
Average pre-COVID depressive symptom | 1.11 | 1.04 | 1.03 | 1.21 | 0.005 | ||||||||||
Average pre-COVID anxiety symptoms | 0.99 | 1.02 | 0.96 | 1.04 | 0.63 | ||||||||||
Average pre-COVID loneliness | 1.37 | 1.06 | 1.23 | 1.85 | <0.001 |
4. Discussion
In the current paper, we extended our previous analyses of mental health trajectories during the COVID-19 pandemic [16,34] by using a GMM approach and a long follow-up of almost two years. In addition, we focused on persons with psychiatric disorders and a comparison group of healthy controls. Even with the explicit aim to detect heterogeneity in mental health trajectories, we found that trajectories mainly differed in level but not the type of change; the majority of the sample had relatively stable trajectories of mental health symptoms. For depressive symptoms we found that 72% was classified in a low/intermediate decreasing trajectory and for anxiety symptoms 90% was classified in a stable low trajectory. Heterogeneity in loneliness trajectories was larger: 61% of the participants were classified in a stable low trajectory, and we found sub-groups with substantial increases and decreases, yet these groups returned to the initial loneliness level by February 2022.
Relative stability in depression and anxiety symptoms is largely in line with other studies [[9], [10], [11],44,45] and our previous analysis of the first month and year of the pandemic [16,34]. One explanation could be that newly available resources, for instance social cohesion, cushioned against the negative consequences of the pandemic [46]. Another explanation might be that lockdown measures have slowed down daily life and therefore have reduced time pressure and mental distress offsetting most pandemic related stressors [18]. In contrast to other studies [11,17,22], we did not find a clear recovering or temporarily elevated sub-group with depressive or anxiety symptoms. This might be because persons with chronic psychiatric disorders on average have a higher and more stable severity of symptoms than persons in the general population. Also possible is that sub-groups with substantial changes in mental health may be small and our sample size was insufficient to detect such groups.
In line with other studies [10,16,34,47], loneliness was more dynamic than depressive and anxiety symptoms. An explanation may be that many measures implemented have had a direct and profound impact on face-to-face contact, which conceptually links most closely to loneliness, i.e. the subjective experience of a lack of quantity and/or emotional depth of one's social contacts. In contrast to another study [19], we did not find that changes in loneliness trajectories occurred the higher and lower end of the loneliness continuum. Instead we found variations among those with intermediate levels of loneliness at the start of the pandemic, which included temporary heightened and temporary lowered trajectories. One explanation might be that our study had a longer follow-up time (February 2022 instead of May 2020). Large changes in the medium loneliness levels may have taken a longer time to become visible whereas fluctuations in lower and higher end of the continuum groups appear relatively stable by contrast. In addition the cushioning effect of newly available resources, for instance social cohesion, may have waned over time [46].
Consistent with others, we found that being younger [9,19,22,48], being female [9,11,19,22,48], individuals with a low education level [9] and income [9,19,22] and living alone [48] were associated having less favourable trajectories of depressive, anxiety symptoms or loneliness. We also found that chronicity of pre-pandemic mental disorders and pre-pandemic symptom severity were associated with unfavourable trajectory membership. For depressive symptoms, we found that those being female, having a low income and living alone were at risk of experiencing a stable intermediate instead of stable low trajectories of depressive symptoms. Arguably, females might have been more vulnerable than males during the pandemic because females carry more responsibility combining teleworking with family care and home-schooling duties [17]. Participants who were living alone might have been relatively more socially isolated [19] and participants who had a low income might have been more vulnerable adversities such as job losses or decreases in household income [9]. For anxiety specifically, we found that being younger related to more unfavourable trajectory. Younger compared to older individuals may have been more affected by job insecurity, balancing child care and teleworking, and by stronger disruptions in daily life because of social distancing and other preventive measures [47,48]. Lastly, for loneliness we found that being female and living alone were associated with unfavourable trajectories.
Strengths of the study are the use of multiple validated symptom severity scales and a well-phenotyped psychiatric status based on diagnostic interviews pre-pandemic. Limitations were selectivity of respondents; responders were less likely to report high chronicity. Therefore, the number of individuals reporting unfavourable trajectories may be underestimated, although stability of the trajectories would likely remain the same. The small sample size may have prohibited the detection of heterogeneity in mental health trajectories during the pandemic, especially for the outcomes of anxiety and depressive symptoms. For depression and anxiety we found that a 4-class and the 3-class solution, respectively, that contained one sub-group of 3%. Although some fit indices suggested an improvement of model fit over the 3 and 2-class models (i.e. lowered BIC), the slopes and quadratic slopes did not reach beyond the threshold of statistical significance, indicating a lack of statistical robustness. Moreover, accepting a model with a small latent class (i.e. N = 51 or N = 48) was not in line with recommendations in the literature [39]. Future studies may repeat this analysis using larger psychiatric samples. Lastly, the fact that this study was conducted among psychiatric cohorts makes generalizability to the general population limited, although this is not the goal of case-control studies.
Overall, we conclude that trajectories of depressive and anxiety symptoms during the pandemic were relatively stable among persons with psychiatric disorders in the Netherlands. For depressive and anxiety symptoms we nevertheless found small yet concerning groups with stable high levels of symptoms. Pre-pandemic mental health status formed a major risk factor for having such trajectories whereas being female, having a low income and living alone formed a risk for depression and being younger for anxiety. For loneliness a greater heterogeneity of trajectories emphasize that lockdown measures such as in the COVID-19 pandemic may have very different consequences for different population groups, although also here, the long-term consequences might be limited. We identified two risk groups of stable high (17%), and temporary heightened (13%)levels. The former was characterized by being female, living alone and having a more depressive symptoms and loneliness pre-pandemic while the latter was characterized by more depressive symptoms and loneliness pre-pandemic.
Funding sources
COVID online data collection and analyses were partly funded by a ‘fast track grant’ from the Dutch Research Council (grant no 440.20.009) and by the RESPOND project which has received funding from the European Union's Horizon 2020 research and innovation programme Societal Challenges under grant agreement No 101016127. The infrastructure for the NESDA study is funded through the Geestkracht programme of the Netherlands Organisation for Health Research and Development (grant no 10–000-1002) and financial contributions by participating universities and mental health-care organisations (VU University Medical Center, Geestelijke Gezondheidszorg (GGZ) inGeest, Leiden University Medical Center, Leiden University, GGZ Rivierduinen, University Medical Center Groningen, University of Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Rob Giel Onderzoekscentrum). The infrastructure for the NESDO study is funded through the Fonds NutsOhra (project 0701–065), Stichting tot Steun VCVGZ, NARSAD The Brain and Behaviour Research Fund (grant id 41080), and by participating universities and mental health-care organisations (VU University Medical Center, Leiden University Medical Center, University Medical Center Groningen, University Medical Center St Radboud, GGZ inGeest, GGNet, GGZ Nijmegen, GGZ Rivierduinen, Lentis, and Parnassia). The infrastructure for the NOCDA study is funded by participating universities and mental health-care organisations (Academic Department VU Medical Center, GGZ inGeest, Innova Research Centre, Mental Health Care Institute GGZ Centraal, Marina de Wolf Anxiety Research Centre, Center for Anxiety Disorders Overwaal, Dimence, GGZ Overijssel, Department of Psychiatry at Leiden University Medical Center, Vincent van Gogh Institute Mental Health Care Centre, Academic Anxiety Center, PsyQ Maastricht University, Division Mental Health and Neuroscience, and Stichting tot Steun VCVGZ). This work was supported by a research grant from Stichting tot Steun VCVGZ [grant number 267]. The funding body did not play a role in the design, execution, analysis and interpretation of data, or writing of the study.
Ethical considerations
The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures involving human subjects/patients were approved by the Institutional Review Board of the Vrije Universiteit Medical Center, Amsterdam, and adhered to the Declaration of Helsinki.
Declaration of Competing Interest
BWJHP reports grants from Janssen Research and Boehringer Ingelheim, outside of the submitted work. All other authors declare no competing interests.
Acknowledgement
We thank all NESDA, NESDO and NOCDA participants for their valuable contributions to the studies as participants.
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.jpsychores.2022.111138.
Appendix A. Supplementary data
Supplementary material
Data availability
According to European law (General Data Protection Regulation), data containing potentially identifying or sensitive patients' information are restricted. However, for academic researchers, data can be made available on request via the NESDA (nesda@ggzingeest.nl), NESDO (d.rhebergen@ggzcentraal.nl), and NOCDA (p.vanoppen@ggzingeest.nl) data access committees.
References
- 1.Bueno-Notivol J., Gracia-García P., Olaya B., Lasheras I., López-Antón R., Santabárbara J. Prevalence of depression during the COVID-19 outbreak: a meta-analysis of community-based studies. Int. J. Clin. Health Psychol. 2021;21(1) doi: 10.1016/j.ijchp.2020.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Xiong J., Lipsitz O., Nasri F., Lui L.M., Gill H., Phan L., et al. Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J. Affect. Disord. 2020;277:55–64. doi: 10.1016/j.jad.2020.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Wu T., Jia X., Shi H., Niu J., Yin X., Xie J., et al. Prevalence of mental health problems during the COVID-19 pandemic: a systematic review and meta-analysis. J. Affect. Disord. 2021;281:91–98. doi: 10.1016/j.jad.2020.11.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Prati G., Mancini A.D. The psychological impact of COVID-19 pandemic lockdowns: a review and meta-analysis of longitudinal studies and natural experiments. Psychol. Med. 2021;1-11 doi: 10.1017/S0033291721000015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Bryan C.J., Bryan A.O., Baker J.C. Associations among state-level physical distancing measures and suicidal thoughts and behaviors among US adults during the early COVID-19 pandemic. Suicide Life Threat. Behav. 2020;50(6):1223–1229. doi: 10.1111/sltb.12653. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Santabárbara J., Lasheras I., Lipnicki D.M., Bueno-Notivol J., Pérez-Moreno M., López-Antón R., et al. Prevalence of anxiety in the COVID-19 pandemic: an updated meta-analysis of community-based studies. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2021;109 doi: 10.1016/j.pnpbp.2020.110207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Sousa GmdJ, Tavares VddO, de Meiroz Grilo M.L.P., Coelho M.L.G., Lima-Araújo Gld, Schuch F.B., et al. Mental health in COVID-19 pandemic: a meta-review of prevalence meta-analyses. Front. Psychol. 2021:4019. doi: 10.3389/fpsyg.2021.703838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Clemente-Suárez V.J., Martínez-González M.B., Benitez-Agudelo J.C., Navarro-Jiménez E., Beltran-Velasco A.I., Ruisoto P., et al. The impact of the COVID-19 pandemic on mental disorders. A critical review. Int. J. Environ. Res. Public Health. 2021;18(19):10041. doi: 10.3390/ijerph181910041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Fancourt D., Steptoe A., Bu F. Trajectories of anxiety and depressive symptoms during enforced isolation due to COVID-19 in England: a longitudinal observational study. Lancet Psychiatry. 2021;8(2):141–149. doi: 10.1016/S2215-0366(20)30482-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Varga T.V., Bu F., Dissing A.S., Elsenburg L.K., Bustamante J.J.H., Matta J., et al. Loneliness, worries, anxiety, and precautionary behaviours in response to the COVID-19 pandemic: a longitudinal analysis of 200,000 Western and northern Europeans. Lancet Reg. Health-Europe. 2021;2 doi: 10.1016/j.lanepe.2020.100020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Pierce M., McManus S., Hope H., Hotopf M., Ford T., Hatch S.L., et al. Mental health responses to the COVID-19 pandemic: a latent class trajectory analysis using longitudinal UK data. Lancet Psychiatry. 2021;8(7):610–619. doi: 10.1016/S2215-0366(21)00151-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Saunders R., Buckman J.E., Leibowitz J., Cape J., Pilling S. Trends in depression & anxiety symptom severity among mental health service attendees during the COVID-19 pandemic. J. Affect. Disord. 2021;289:105–109. doi: 10.1016/j.jad.2021.04.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Bower M., Smout S., Donohoe-Bales A., Teesson L., Lauria E., Boyle J., et al. 2022. A Hidden Pandemic? An Umbrella Review of Global Evidence on Mental Health in the Time of COVID-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Robinson E., Sutin A.R., Daly M., Jones A. A systematic review and meta-analysis of longitudinal cohort studies comparing mental health before versus during the COVID-19 pandemic in 2020. J. Affect. Disord. 2022;296:567–576. doi: 10.1016/j.jad.2021.09.098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Ernst M., Niederer D., Werner A.M., Czaja S.J., Mikton C., Ong A.D., et al. Loneliness before and during the COVID-19 pandemic: a systematic review with meta-analysis. Am. Psychol. 2022;77(5):660–677. doi: 10.1037/amp0001005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kok A.A., Pan K.-Y., Ottenheim N.R., Jörg F., Eikelenboom M., Horsfall M., et al. Mental health and perceived impact during the first Covid-19 pandemic year: a longitudinal study in Dutch case-control cohorts of persons with and without depressive, anxiety, and obsessive-compulsive disorders. J. Affect. Disord. 2022;305:85–93. doi: 10.1016/j.jad.2022.02.056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ellwardt L., Präg P. Heterogeneous mental health development during the COVID-19 pandemic in the United Kingdom. Sci. Rep. 2021;11(1):1–7. doi: 10.1038/s41598-021-95490-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kuhn U., Klaas H.S., Antal E., Dasoki N., Lebert F., Lipps O., et al. Who is most affected by the Corona crisis? An analysis of changes in stress and well-being in Switzerland. Eur. Soc. 2021;23(sup1):S942–S956. [Google Scholar]
- 19.Bu F., Steptoe A., Fancourt D. Loneliness during a strict lockdown: trajectories and predictors during the COVID-19 pandemic in 38,217 United Kingdom adults. Soc. Sci. Med. 2020;265 doi: 10.1016/j.socscimed.2020.113521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Batterham P.J., Calear A.L., McCallum S.M., Morse A.R., Banfield M., Farrer L.M., et al. Trajectories of depression and anxiety symptoms during the COVID-19 pandemic in a representative Australian adult cohort. Med. J. Aust. 2021;214(10):462–468. doi: 10.5694/mja2.51043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.McPherson K.E., McAloney-Kocaman K., McGlinchey E., Faeth P., Armour C. Longitudinal analysis of the UK COVID-19 psychological wellbeing study: trajectories of anxiety, depression and COVID-19-related stress symptomology. Psychiatry Res. 2021;304 doi: 10.1016/j.psychres.2021.114138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Saunders R., Buckman J.E., Fonagy P., Fancourt D. Understanding different trajectories of mental health across the general population during the COVID-19 pandemic. Psychol. Med. 2021;1-9 doi: 10.1017/S0033291721000957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Shevlin M., Butter S., McBride O., Murphy J., Gibson-Miller J., Hartman T.K., et al. Refuting the myth of a ‘tsunami’of mental ill-health in populations affected by COVID-19: evidence that response to the pandemic is heterogeneous, not homogeneous. Psychol. Med. 2021;1-9 doi: 10.1017/S0033291721001665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Joshi D., Gonzalez A., Griffith L., Duncan L., MacMillan H., Kimber M., et al. The trajectories of depressive symptoms among working adults during the COVID-19 pandemic: a longitudinal analysis of the InHamilton COVID-19 study. BMC Public Health. 2021;21(1):1–10. doi: 10.1186/s12889-021-11900-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Kotwal A.A., Batio S., Wolf M.S., Covinsky K.E., Yoshino Benavente J., Perissinotto C.M., et al. Persistent loneliness due to COVID-19 over 18 months of the pandemic: a prospective cohort study. J. Am. Geriatr. Soc. 2022;70(12):3469–3479. doi: 10.1111/jgs.18010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kimhi S., Eshel Y., Marciano H., Adini B., Bonanno G.A. Trajectories of depression and anxiety during COVID-19 associations with religion, income, and economic difficulties. J. Psychiatr. Res. 2021;144:389–396. doi: 10.1016/j.jpsychires.2021.10.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Burkova V.N., Butovskaya M.L., Randall A.K., Fedenok J.N., Ahmadi K., Alghraibeh A.M., et al. Predictors of anxiety in the COVID-19 pandemic from a global perspective: data from 23 countries. Sustainability. 2021;13(7):4017. [Google Scholar]
- 28.Penninx B.W., Eikelenboom M., Giltay E.J., van Hemert A.M., Riese H., Schoevers R.A., et al. Cohort profile of the longitudinal Netherlands study of depression and anxiety (NESDA) on etiology, course and consequences of depressive and anxiety disorders. J. Affect. Disord. 2021;287:69–77. doi: 10.1016/j.jad.2021.03.026. [DOI] [PubMed] [Google Scholar]
- 29.Comijs H.C., van Marwijk H.W., van der Mast R.C., Naarding P., Voshaar R.C.O., Beekman A.T., et al. The Netherlands study of depression in older persons (NESDO); a prospective cohort study. BMC Res. Notes. 2011;4(1):1–10. doi: 10.1186/1756-0500-4-524. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Schuurmans J., van Balkom A.J., van Megen H.J., Smit J.H., Eikelenboom M., Cath D.C., et al. The Netherlands obsessive compulsive disorder association (NOCDA) study: design and rationale of a longitudinal naturalistic study of the course of OCD and clinical characteristics of the sample at baseline. Int. J. Methods Psychiatr. Res. 2012;21(4):273–285. doi: 10.1002/mpr.1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Rush A.J., Trivedi M.H., Ibrahim H.M., Carmody T.J., Arnow B., Klein D.N., et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol. Psychiatry. 2003;54(5):573–583. doi: 10.1016/s0006-3223(02)01866-8. [DOI] [PubMed] [Google Scholar]
- 32.Beck A.T., Epstein N., Brown G., Steer R.A. An inventory for measuring clinical anxiety: psychometric properties. J. Consult. Clin. Psychol. 1988;56(6):893. doi: 10.1037//0022-006x.56.6.893. [DOI] [PubMed] [Google Scholar]
- 33.Gierveld J.D.J., Tilburg T.V. A 6-item scale for overall, emotional, and social loneliness: confirmatory tests on survey data. Res. Aging. 2006;28(5):582–598. [Google Scholar]
- 34.Pan K.-Y., Kok A.A., Eikelenboom M., Horsfall M., Jörg F., Luteijn R.A., et al. The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts. Lancet Psychiatry. 2021;8(2):121–129. doi: 10.1016/S2215-0366(20)30491-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Wittchen H.-U. Reliability and validity studies of the WHO-composite international diagnostic interview (CIDI): a critical review. J. Psychiatr. Res. 1994;28(1):57–84. doi: 10.1016/0022-3956(94)90036-1. [DOI] [PubMed] [Google Scholar]
- 36.First M.B., Spitzer R.L., Gibbon M., Williams J.B. User’s guide for the Structured Clinical Interview for DSM-IV axis I disorders (SCID-I): clinician version. American Psychiatric Press; New York, NY: 1996. [Google Scholar]
- 37.Jung T., Wickrama K.A. An introduction to latent class growth analysis and growth mixture modeling. Soc. Personal. Psychol. Compass. 2008;2(1):302–317. [Google Scholar]
- 38.Ram N., Grimm K.J. Methods and measures: growth mixture modeling: a method for identifying differences in longitudinal change among unobserved groups. Int. J. Behav. Dev. 2009;33(6):565–576. doi: 10.1177/0165025409343765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Nylund K.L., Asparouhov T., Muthén B.O. Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Struct. Equ. Model. Multidiscip. J. 2007;14(4):535–569. [Google Scholar]
- 40.Clark S.L., Muthén B. 2009. Relating Latent Class Analysis Results to Variables Not Included in the Analysis. Los Angeles, California, USA. [Google Scholar]
- 41.Lo Y. Likelihood ratio tests of the number of components in a normal mixture with unequal variances. Statist. Probability Lett. 2005;71(3):225–235. [Google Scholar]
- 42.Lo Y., Mendell N.R., Rubin D.B. Testing the number of components in a normal mixture. Biometrika. 2001;88(3):767–778. [Google Scholar]
- 43.Asparouhov T., Muthén B. Auxiliary variables in mixture modeling: three-step approaches using M plus. Struct. Equ. Model. Multidiscip. J. 2014;21(3):329–341. [Google Scholar]
- 44.O’Connor R.C., Wetherall K., Cleare S., McClelland H., Melson A.J., Niedzwiedz C.L., et al. Mental health and well-being during the COVID-19 pandemic: longitudinal analyses of adults in the UK COVID-19 Mental Health & Wellbeing study. Br. J. Psychiatry. 2021;218(6):326–333. doi: 10.1192/bjp.2020.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Wang C., Pan R., Wan X., Tan Y., Xu L., McIntyre R.S., et al. A longitudinal study on the mental health of general population during the COVID-19 epidemic in China. Brain Behav. Immun. 2020;87:40–48. doi: 10.1016/j.bbi.2020.04.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Borkowska M., Laurence J. Coming together or coming apart? Changes in social cohesion during the Covid-19 pandemic in England. Eur. Soc. 2021;23(sup1):S618–S636. [Google Scholar]
- 47.Van Tilburg T.G., Steinmetz S., Stolte E., van der Roest H., de Vries D.H. Loneliness and mental health during the COVID-19 pandemic: a study among Dutch older adults. J. Gerontol.: Series B. 2021;76(7):e249–e255. doi: 10.1093/geronb/gbaa111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Ottenheim N.R., Pan K.-Y., Kok A.A., Jörg F., Eikelenboom M., Horsfall M., et al. Predictors of mental health deterioration from pre-to post-COVID-19 outbreak. BJ Psych. Open. 2022;8(5) doi: 10.1192/bjo.2022.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplementary material
Data Availability Statement
According to European law (General Data Protection Regulation), data containing potentially identifying or sensitive patients' information are restricted. However, for academic researchers, data can be made available on request via the NESDA (nesda@ggzingeest.nl), NESDO (d.rhebergen@ggzcentraal.nl), and NOCDA (p.vanoppen@ggzingeest.nl) data access committees.